Clinical trial
A Multicenter Extension Study to Determine the Long-Term Safety and Efficacy of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis
NCT02555215 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Extension Study to Determine the Long-Term Safety and Efficacy of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis
- Lead sponsor
- Biogen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 22, 2016
- Completion date
- September 24, 2018
- Enrollment
- 20 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.